• Amazon CFO: We Have Too Much Space, Too Many People
• This Week's D.C. Deal Sheet
• Industrial And BTR Deals Heat Up Irish Investment Market
• Philadelphia's Affordable Housing Plan Comes Into Focus: 1,000 Single-Family Homes On City Land
• Boston Properties Signs Pharma Giant To 570K SF Build-To-Suit In Kendall Square
• This Week's Houston Deal Sheet
• Weekend Interview: Largo Co-Founder Nicholas Werner
• Carbon-Free Cement Startup Raises $55M Series A Led By Bill Gates' VC Firm
• The Arts District's Rendon Hotel Project Gets Planning Commission Approval
• JS Sullivan Submits Development Plans For Tenderloin Mixed-Use Community
• Brookfield, Tishman Speyer Make Big Push Into Life Sciences
• Finance, Tech Giants Using Their Wallets To Drive DEI Improvements Across CRE
• Record Demand Overcomes Headwinds To Give Data Center REITs Strong First Quarter
• LA Leads U.S. In Office-To-Life Sciences Conversion Growth
• Ashkenazy Battling Lawsuits, Dodging Foreclosures As Grasp Slips On Iconic Properties
• This Week's London Deal Sheet
• Jamestown Partners With BitPay For Cryptocurrency Rent Payments
• OSHA Recommends Safety Review Of Amazon Warehouses After Probe Into Fatal Collapse
• Overhaul Of Dallas Housing Policy Seeks To Undo History Of Racist Practices
• Huge Mixed-Use Development Legacy Hills Gets Underway in Celina
• Beverly Grove Retail-To-Residential Redevelopment The First In TAC's 'Tweener Sites' Fund
• Hersha Sells Hotels In D.C., LA, Boston, Philadelphia For Combined $505M
• Tunnels Under Fort Lauderdale? City In Talks With Elon Musk's The Boring Co.
• International Duo Win Bid To Convert John Lewis Store To £750M Office
• D.C. Aims To Invest $92M In Life Sciences Capital Projects Across 4 Campuses
• Tomball City Council Dashes Plans For Upcoming David Weekley Homes Community
• A Suburban Judge Has Become The Go-To For NYC Developers In Bankruptcy
• Flagship Michigan Avenue Store Changes Hands As Mag Mile Tries To Find Footing
• Alexandria’s Top Tenants Help Life Sciences Leader Weather New 'Have And Have-Not' Era Of Biotech
• This Week's Atlanta Deal Sheet